The estimated Net Worth of Carol Wrenn is at least $981 mil dollars as of 23 May 2017. Ms. Wrenn owns over 1,630 units of Phibro Animal Health stock worth over $126,258 and over the last 21 years she sold PAHC stock worth over $794,557. In addition, she makes $60,000 as Independent Director at Phibro Animal Health.
Carol has made over 12 trades of the Phibro Animal Health stock since 2003, according to the Form 4 filled with the SEC. Most recently she exercised 1,630 units of PAHC stock worth $13,203 on 23 May 2017.
The largest trade she's ever made was exercising 42,000 units of Phibro Animal Health stock on 1 February 2007 worth over $856,380. On average, Carol trades about 4,675 units every 173 days since 2003. As of 23 May 2017 she still owns at least 6,174 units of Phibro Animal Health stock.
You can see the complete history of Ms. Wrenn stock trades at the bottom of the page.
Carol A. Wrenn serves as Independent Director of the Company. Ms. Wrenn has been a director since July 2010. Ms. Wrenn also serves as a member of the Audit Committee and the Compensation Committee. She is the founder and owner of Whitewater Advisors LLC, which provides consulting services to small businesses and 50% owner of Aurora Borealis LLC, which operates online retail businesses. She was the founder and owner of Sky River Helicopters, LLC, a company that provided helicopter charters, tours, commercial services and lessons, from January 2010 until September 2015. She previously served as an Executive Vice President and the President of the Animal Health Division at Alpharma Inc., a human and animal pharmaceutical company, from November 2001 to June 2009. From April 2007 to April 2009, Ms. Wrenn also held the position of Chairman of the Animal Health Institute, an industry organization advocating for animal health issues, including efficient and effective FDA, USDA and EPA regulatory and approval processes. From January 2002 to June 2009, she was an active member of the board of directors of the International Federation of Animal Health. Prior to joining Alpharma, Ms. Wrenn held various executive positions at Honeywell International Inc. (formerly, AlliedSignal Inc.) from 1984 to 2001. She served as Business Director of Honeywell’s Refrigerants, Fluorine Products Division from 2000 to 2001 and was the Commercial Director and Managing Director of Honeywell’s European Fluorochemical operations based in Haasrode, Belgium from 1997 to 2000. Ms. Wrenn also held a number of positions in sales, marketing, business development and finance during her tenure with AlliedSignal. Ms. Wrenn served as a director of Heska Corporation from January 2013 until May 2019. She holds a Bachelor’s Degree from Union College, an MBA from Lehigh University and a DBA from California Southern University. Ms. Wrenn is qualified to serve on our Board of Directors due to her relevant industry experience, strategic and problem-solving
As the Independent Director of Phibro Animal Health, the total compensation of Carol Wrenn at Phibro Animal Health is $60,000. There are 11 executives at Phibro Animal Health getting paid more, with Richard Johnson having the highest compensation of $6,293,240.
Carol Wrenn is 59, she's been the Independent Director of Phibro Animal Health since 2010. There are 11 older and 10 younger executives at Phibro Animal Health. The oldest executive at Phibro Animal Health Corp. is Gerald Carlson, 77, who is the Independent Director.
Carol's mailing address filed with the SEC is , , , , .
Over the last 10 years, insiders at Phibro Animal Health have traded over $195,476,671 worth of Phibro Animal Health stock and bought 26,000 units worth $514,940 . The most active insiders traders include L.P. Mayflower, Co., Llc Bfi y Jack Bendheim. On average, Phibro Animal Health executives and independent directors trade stock every 17 days with the average trade being worth of $962,991. The most recent stock trade was executed by E Thomas Corcoran on 4 September 2024, trading 5,000 units of PAHC stock currently worth $100,100.
phibro animal health corporation is a leading global diversified animal health and mineral nutrition company. we are dedicated to helping meet the growing demand for animal protein. we concentrate exclusively on animals for food production and are one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. for over 40 years we have been committed to providing livestock producers with value-based products and solutions to help them maintain and enhance the health of their animals. we develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. our products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. phibro animal health corporation reported net sales of $764 million for the fiscal year ended june 30, 2017. our more than 1,400 employees are proud to manufacture and market our
Phibro Animal Health executives and other stock owners filed with the SEC include: